MS Center of Greater Washington

Vienna, Virginia 22182

0 studies enrolling now · 5 studies all time

What they study most

Central Neuropathic Pain, Multiple Sclerosis, Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Primary Progressive Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis — Completed
• Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis — Stopped early
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS) — Status unconfirmed